Welcome

Ahmad Zia “Lodin” M.Umar Farooq Khan Habibullah

Group Members

Introduction History Mission and Vision Organization & Culture Strategy & Managing Change Global Prospective SWOT Analysis Conclusion

Layout

GlaxoSmithKline (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in Brent ford, London. As of March 2014, it was the world's sixth-largest pharmaceutical company after Johnson & Johnson, Novartis , Hoffmann-La Roche, Pfizer, and Sanofi, measured by 2013 revenue.

Introduction

GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London Stock Exchange and the New York Stock Exchange. 

On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies.

History

History GSK and its subsidiary and associated undertakings constitute a major global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products.

GSK has its corporate head office in London and has its US headquarters in Research Triangle Park, North Carolina, with operations in some 120 countries, and products sold in over 150 countries.

Con…

Mission and Vision

‘’Improve the quality of human life by enabling people to do more, feel better and live longer’’.

Mission

We carry out our business with the enthusiasm of entrepreneurs, excited by the constant search for innovation.

We also have a strong culture of performance achieved with integrity.

We are confident of attaining our set goals because our people bring to the workplace an attitude of passion and positive attitude.

Vision

Organization

BOD CEO Deout Chairman

Advisory committee on administration

development

Trade net Dept

Sales

Managemen

t Dept

Quality Control Dep

t

Finance Dept

Human

resource

s Dep

t

Marketing Managemen

t Dept

International Trade Ins

General Administration Dept

Planning and finance Dept

Overseas & Domestic Branch Office

National Sales Dept

Provisional sales Dept

Area Sales Dept

Product Line Q.C

Dept

Product Q.C Dept

Audit

Dept

Strategic Manage

ment Dept

Product Manage

ment Dept

Selection & Recruitment Dept

The management levels of GSK are as follows:-

Executive Level

Director Level

Manager Level

Staff

The main challenge for GSK; Use of Un-ethical practices in the

market

Challenge In Market

But as GSK is a trustworthy Multi National brand (Controlled from UK).Has a developed an Anti Bribery department.Customer has a trust on GSK.For making this trust even stronger & assuring transparency, The MRs (Medical Representative) are given no Sales targets to avoid the use of unfair sales purposes in the lower staff.

Respect people Patient focus Transparency Integrity In GSK, MR has the same respect as that

of the MD. Empowerment of the staff & Team work

Organizational Culture

Change In Manager Job

In market we have to highlight the plus points of our product and the negatives of the competitors.

For example: competitive products. Both are used for Respiratory Tract

Infections.

Competitive Strategy

Why people resist CHANGE?

Lack of expertise is the main reason. GSK follows the Top down Bottom up design.

Managing Change

GSK has same basic strategies all over the world. But the secondary strategies are aligned with the market. As we believe on the policy of,

“Think Globally Act Locally”

GSK has the main focus on emerging markets (Mainly China & other Asian countries)

Global Prospective

While our products can mainly be divided into:

Innovative Products More investment,

higher profitability & are the future of the Co. Mature Products Not much Investments.

E.g. Ampiclox Classical Products Big volumes but still

have less growth as compared to innovative products. Lesser investments.

Cont…

Strengths Strong management team. Large market share. Majority research based products in

Pakistan. Wide range of products.

SWOT Analysis

Less checking on the sales representatives for their working in the field.

Weaknesses

High growth rate in emerging market of pharma business.

One of the good brand names in pharma industry.

GSK can be able to cash its name in baby foods.

Opportunities

Lower cost competitors or imports like Chinese and Indian medicines etc

Un-ethical practices while GSK have strong SOPs.

Mighty company so lower growths. Instability of the country .

Threats

Working in a competitive & the market where un-ethical practices are common is very hard.But still continuous hard work on the behavior and values of the organization and its employees can be fruitful, i-e Expanding profits.

Conclusion

Thank you

Q & A